S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility
Quentin M. Anstee(Newcastle upon Tyne Hospital), Christopher P. Day(Newcastle University)
Cited by 236
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k